Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Tonghui Pharmaceutical is a comprehensive pharmaceutical service provider based in China, specializing in the supply chain management of Active Pharmaceutical Ingredients (APIs), excipients, and pharmaceutical packaging materials. Established in 1999, the company acts as a strategic bridge between global chemical manufacturers and the Chinese domestic market, providing essential services such as regulatory registration (DMF/IDL), market access consulting, and technical distribution. Beyond distribution, Tonghui operates a dedicated R&D center that supports generic drug development, consistency evaluation, and formulation optimization. The company's expertise in navigating the National Medical Products Administration (NMPA) regulatory landscape makes it a key partner for international firms looking to commercialize products in China. Tonghui's business model integrates professional sales with high-end contract research services, focusing primarily on small molecule therapeutics across a wide range of indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 广州市桐晖药业.